| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 53.068 | 74.831 | 106.011 | 150.087 | 144.547 | 84.140 | 95.240 | 109.731 | 98.718 | 108.236 |
| Total Income - EUR | 53.107 | 75.401 | 106.011 | 150.099 | 144.596 | 84.154 | 95.247 | 109.731 | 119.857 | 109.013 |
| Total Expenses - EUR | 72.594 | 58.710 | 59.108 | 141.514 | 82.501 | 37.624 | 63.884 | 48.676 | 115.124 | 96.846 |
| Gross Profit/Loss - EUR | -19.488 | 16.691 | 46.903 | 8.585 | 62.096 | 46.530 | 31.363 | 61.055 | 4.734 | 12.167 |
| Net Profit/Loss - EUR | -21.080 | 15.943 | 45.843 | 7.084 | 60.650 | 45.754 | 28.909 | 57.763 | 1.987 | 10.196 |
| Employees | 7 | 4 | 5 | 4 | 3 | 2 | 1 | 0 | 0 | 1 |
Check the financial reports for the company - Ciuperca Bio Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 53 | 13 | 13 | 926 | 578 | 2.454 | 1.673 | 40.145 | 149.455 | 143.657 |
| Current Assets | 16.806 | 13.453 | 25.666 | 29.453 | 73.287 | 114.041 | 141.183 | 107.706 | 75.199 | 123.282 |
| Inventories | 7.108 | 716 | 549 | 539 | 2.842 | 2.788 | 2.373 | 7.450 | 2.464 | 49.484 |
| Receivables | 8.422 | 675 | 10.394 | 11.364 | 11.923 | 8.437 | 8.471 | 15.771 | 28.917 | 40.882 |
| Cash | 1.277 | 12.062 | 14.723 | 17.550 | 58.522 | 102.816 | 130.339 | 84.484 | 43.818 | 32.916 |
| Shareholders Funds | -40.272 | -23.918 | 22.330 | 29.004 | 89.092 | 133.157 | 159.124 | 130.720 | 140.876 | 149.474 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 51 | 51 | 51 | 50 |
| Debts | 57.130 | 37.384 | 3.348 | 2.097 | 1.708 | 1.276 | 1.272 | 34.725 | 83.778 | 117.465 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "113 - 113" | |||||||||
| CAEN Financial Year |
113
|
|||||||||
Comments - Ciuperca Bio Srl